Production (Stage)
MediWound Ltd.
MDWD
$20.33
-$0.53-2.54%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -22.51% | -23.32% | -29.48% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -22.51% | -23.32% | -29.48% | |
| Cost of Revenue | -- | 30.02% | 23.47% | 13.33% | |
| Gross Profit | -- | -78.74% | -73.19% | -72.82% | |
| SG&A Expenses | -- | -5.21% | 2.69% | 12.25% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -100.00% | -100.00% | |
| Total Operating Expenses | -- | 1.77% | 0.84% | 0.67% | |
| Operating Income | -- | -72.88% | -74.03% | -107.65% | |
| Income Before Tax | -- | -37.90% | 36.06% | 66.54% | |
| Income Tax Expenses | -- | 118.39% | 158.23% | 137.18% | |
| Earnings from Continuing Operations | -- | -38.38% | 35.28% | 65.73% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -38.38% | 35.28% | 65.73% | |
| EBIT | -- | -72.88% | -74.03% | -107.65% | |
| EBITDA | -- | -82.19% | -84.86% | -128.16% | |
| EPS Basic | -- | 9.84% | 59.56% | 80.05% | |
| Normalized Basic EPS | -- | -3.14% | 63.60% | 72.38% | |
| EPS Diluted | -- | 9.84% | 59.56% | 80.05% | |
| Normalized Diluted EPS | -- | -3.14% | 63.60% | 72.38% | |
| Average Basic Shares Outstanding | -- | 28.69% | 52.16% | 80.58% | |
| Average Diluted Shares Outstanding | -- | 28.69% | 52.16% | 80.58% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |